CG
ENTG icon

Cynosure Group’s Entegris ENTG Stock Holding History

Cynosure Group’s Portfolio ENTG Stock Details ENTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,804
Closed -$573K – 287
2025
Q4 		$573K Buy
+6,804
New +$591K 0.06% 118

Other funds holding ENTG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cynosure Group's ENTG Position: Q1 2026 in Review

Cynosure Group sold out of Entegris (ENTG) in Q1 2026, closing a stake of 6,804 shares — an estimated $573K sold.

Cynosure Group first reported a position in ENTG in Q4 2025 and held it in 1 quarter. The position peaked at $573K in Q4 2025. 643 funds tracked by Wall St. Rank hold ENTG as of Q1 2026.

  • Cynosure Group reported no remaining Entegris position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 6,804 Entegris shares in Q1 2026, an estimated $573K.
  • Cynosure Group first reported a position in Entegris in Q4 2025 and held it in 1 quarter.
  • Cynosure Group's Entegris position peaked at $573K in Q4 2025.
  • 643 funds tracked by Wall St. Rank held Entegris as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.